It also accords with studies that indicate inconclusive effects of APOE e4 at younger ages on cognitive and brain-imaging markers (51, 52), although there is evidence for an effect of e4 (especially for e4e4 homozygotes) on poorer brain white matter health in middle to older aged people without dementia (53). The gene discussed is APOE; the disease is dementia.